Memory immune responses provide enhanced protection from pathogens previously encountered, and are remarkably long-lived, persisting over a lifetime of an individual. The ability of the immune system to generate memory is the basis for the success of many vaccines in preventing or eradicating deadly diseases; however, generation of immune memory that protects against infectious agents such as HIV, malaria and many bacterial pathogens has remained elusive. Memory immune responses begin with recognition of an antigen by naive T cells via their cell surface T cell antigen receptor (TCR) resulting in proliferation and differentiation to activated effector cells producing cytokines to recruit and activate immune cells from antigen clearance. Most of these activated effector cells die, but a small proportion of activated and/or effector T cells persists as memory T cells that mediate an enhanced recall response for rapid antigen clearance. Aside from this general scheme, the mechanisms by which immune memory is generated, how it mediates superior immune reactions, and how it is maintained in the host are largely unknown. We have taken a biochemical approach to dissect the signal transduction pathways mediated through the TCR in naive, effector and memory CD4 T cells to understand the mechanisms controlling their diverse functions, lifespans, and activation properties. We found that while naive T cells exhibit TCR- coupled signaling similar to T cell lines and clones, effector T cells are marked by a striking amplification of signals and alteration of the proximal TCR signaling complex, and memory CD4 T cells exhibit a profound dampening of signaling, with a remarkable decrease in expression of the critical linker/adapter molecule SLP-76. These results suggest the hypothesis that TCR-mediated signaling changes drive T cell differentiation to effector and memory subsets. It is the goal of this proposal to directly test this hypothesis and elucidate the precise roles of specific signaling changes on effector and memory T cell differentiation and function in vitro and in vivo, using biochemical, molecular and cellular immunological approaches. The proposed research has the potential to elucidate precise mechanisms for regulation of memory immune responses on the biochemical level and identify novel targets for manipulation of memory and effector immune responses in anti-pathogen immune responses and in autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042092-10
Application #
7171876
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Ferguson, Stacy E
Project Start
2003-09-30
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2009-01-31
Support Year
10
Fiscal Year
2007
Total Cost
$281,609
Indirect Cost
Name
University of Maryland Baltimore
Department
Surgery
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Lai, Wendy; Yu, Minjun; Huang, Min-Nung et al. (2011) Transcriptional control of rapid recall by memory CD4 T cells. J Immunol 187:133-40
Bushar, Nicholas D; Corbo, Evann; Schmidt, Michelle et al. (2010) Ablation of SLP-76 signaling after T cell priming generates memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis. Proc Natl Acad Sci U S A 107:827-31
Farber, Donna L (2009) Biochemical signaling pathways for memory T cell recall. Semin Immunol 21:84-91
Tang, Anita L; Teijaro, John R; Njau, Modesta N et al. (2008) CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J Immunol 181:1806-13
Okoye, Francesca I; Krishnan, Sandeep; Chandok, Meena R et al. (2007) Proximal signaling control of human effector CD4 T cell function. Clin Immunol 125:5-15
Krishnan, Sandeep; Farber, Donna L; Tsokos, George C (2003) T cell rewiring in differentiation and disease. J Immunol 171:3325-31